A. Harbottle et al., Role of glutathione S-transferase P1, P-glycoprotein and multidrug resistance-associated protein 1 in acquired doxorubicin resistance, INT J CANC, 92(6), 2001, pp. 777-783
While P-glycoprotein (Pgp) and multidrug resistance-associated protein 1 (M
RP1) are known to be important in acquired doxorubicin resistance, the role
of glutathione S-transferases (GST) remains unclear. Our study assessed ro
les of these 3 factors in a human drug-sensitive carcinoma cell line (HEp2)
, a subclone made resistant by prolonged incubation in doxorubicin (HEp2A),
and HEp2 cells stably transfected with human GSTP1, Drug-resistant HEp2A c
ells showed greater total GST activity, GSTP class enzyme expression, Pgp e
xpression, MRP1 transcript expression, drug efflux and at least 13-fold gre
ater resistance to doxorubicin than the parent HEp2 cell line. GSTM class e
nzyme expression was similar in both cell types, while GSTA class enzymes w
ere not detected, In the resistant HEp2A cells, cytotoxicity was markedly e
nhanced by the Pgp/MRP inhibitor verapamil at low doxorubicin concentration
s. The GST inhibitor curcumin also enhanced cytotoxicity in HEp2A cells whe
n the Pgp/MRP efflux barrier had been reversed by verapamil or overcome by
high doxorubicin concentrations. In addition, curcumin had a chemosensitisi
ng effect at low doxorubicin concentrations in HEp2 cells. Stable transfect
ion of HEp2 cells with human GSTP1 increases doxorubicin resistance 3-fold
over control cells. Our study indicates involvement of GSTP enzymes as well
as efflux mechanisms in the acquired doxorubicin-resistance phenotype. (C)
2001 Wiley-Liss, Inc.